Ethics approval and consent to participate
This study was approved by the Medical Ethics Committee of The Sixth Affiliated Hospital of Wenzhou Medica University in Lishui, China (LLW-FO-403) and was registered at the Chinese Clinical Trial Registry (ChiCTR2300069224, 10 March 2023). It adheres to the principles outlined in the Declaration of Helsinki and the CONSORT 2010 guidelines. Informed consent regarding study enrollment and anonymized data collection and publication was obtained from all patients.